Deutsche Bank’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-30,034
Closed -$114K 4448
2020
Q1
$114K Sell
30,034
-2,045
-6% -$7.76K ﹤0.01% 3148
2019
Q4
$162K Sell
32,079
-22,537
-41% -$114K ﹤0.01% 3296
2019
Q3
$275K Sell
54,616
-516,535
-90% -$2.6M ﹤0.01% 2968
2019
Q2
$3.52M Sell
571,151
-766,743
-57% -$4.73M ﹤0.01% 2011
2019
Q1
$6.21M Buy
1,337,894
+1,149,765
+611% +$5.33M ﹤0.01% 1707
2018
Q4
$789K Sell
188,129
-314,858
-63% -$1.32M ﹤0.01% 3012
2018
Q3
$3.15M Buy
502,987
+213,389
+74% +$1.34M ﹤0.01% 2536
2018
Q2
$2.33M Sell
289,598
-74,927
-21% -$603K ﹤0.01% 2839
2018
Q1
$2.72M Buy
364,525
+176,527
+94% +$1.32M ﹤0.01% 2654
2017
Q4
$1.12M Sell
187,998
-195,362
-51% -$1.16M ﹤0.01% 3080
2017
Q3
$2.82M Sell
383,360
-314,474
-45% -$2.31M ﹤0.01% 2294
2017
Q2
$4.74M Buy
697,834
+230,110
+49% +$1.56M ﹤0.01% 1948
2017
Q1
$4.41M Buy
467,724
+60,652
+15% +$572K ﹤0.01% 1741
2016
Q4
$3.52M Sell
407,072
-5,328
-1% -$46K ﹤0.01% 1881
2016
Q3
$2.61M Buy
412,400
+130,454
+46% +$825K ﹤0.01% 2158
2016
Q2
$1.19M Buy
281,946
+127,864
+83% +$539K ﹤0.01% 2736
2016
Q1
$671K Sell
154,082
-6,756
-4% -$29.4K ﹤0.01% 3007
2015
Q4
$985K Sell
160,838
-320,650
-67% -$1.96M ﹤0.01% 2836
2015
Q3
$2.75M Buy
481,488
+224,320
+87% +$1.28M ﹤0.01% 2246
2015
Q2
$1.92M Buy
257,168
+34,802
+16% +$259K ﹤0.01% 2464
2015
Q1
$1.33M Sell
222,366
-146,610
-40% -$876K ﹤0.01% 2681
2014
Q4
$2.79M Buy
368,976
+82,526
+29% +$623K ﹤0.01% 2395
2014
Q3
$1.49M Buy
286,450
+52,439
+22% +$272K ﹤0.01% 2692
2014
Q2
$1.01M Sell
234,011
-26,113
-10% -$112K ﹤0.01% 2884
2014
Q1
$1.06M Sell
260,124
-71,258
-22% -$291K ﹤0.01% 2822
2013
Q4
$1.76M Sell
331,382
-169,238
-34% -$901K ﹤0.01% 2355
2013
Q3
$2.51M Buy
500,620
+58,659
+13% +$294K ﹤0.01% 2324
2013
Q2
$1.97M Buy
+441,961
New +$1.97M ﹤0.01% 2231